| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $154.0M | — | +25.8% |
| Cost of Revenue | $33.6M | — | +11.3% |
| Gross Profit | $120.4M | — | +30.5% |
| R&D Expense | $51.8M | — | +19.6% |
| SG&A Expense | $23.7M | — | +24.6% |
| Operating Income | -$12.9M | — | +43.7% |
| Pre-tax Income | -$5.8M | — | +66.0% |
| Income Tax | $2.5M | — | +66.1% |
| Net Income | -$8.3M | — | +55.3% |
| EPS (Basic) | -$0.07 | — | +56.3% |
| EPS (Diluted) | -$0.07 | — | +56.3% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $61.0M | -19.6% | +37.5% |
| Short-term Investments | $680.3M | +8.2% | +31.0% |
| Accounts Receivable | $113.7M | -5.2% | +34.9% |
| Current Assets | $904.8M | +3.6% | +32.6% |
| Total Assets | $1.37B | +2.4% | +18.8% |
| Current Liabilities | $400.2M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $38.4M | — | +33.2% |
| Capital Expenditures | $1.1M | — | +65.4% |
| Investing Cash Flow | -$53.1M | — | -15.9% |
| Financing Cash Flow | -$150K | — | -101.3% |
| Free Cash Flow | $37.3M | — | +32.5% |
| +25.4% |
| Total Liabilities | $449.2M | -1.0% | +26.1% |
| Stockholders' Equity | $924.0M | +4.1% | +15.5% |